Studying Hemostatic Effect of Axiostat® Dressing on Radial Access After Percutaneous Procedure

To evaluate Safety and Efficacy of Axiostat® hemostatic dressing in terms of time to achieve hemostasis, post application complication and comfort levels of patients who have undergone radial intervention.

Inclusion criteria

• Age greater than or equal to 18 years.
• Patient and/or patient's legal representative and/or impartial witness has/have been informed of the nature of the study and agrees to its provision and has provided written informed consent as approved by the Ethics Committee of the investigative site.
• Iatrogenic puncture
• Patient who want to undergo radial intervention.
• All puncture size must be less than 2.5cm.

Exclusion criteria

• Prior diagnosis of disease or medical condition affecting the ability of blood to clot (e.g., hemophilia.).
• Patients with known sensitivity to chitosan (shellfish) used in this study.
• Patients who, in the opinion of the Investigator, may not complete the study for any reason, e.g. Patient requiring Immediate suturing.
• Patient is currently participating in an investigational drug or dressing study that has not yet completed its primary endpoint interferes with procedure and assessments in this trial.
• Pregnant women.
• Patients with hemorrhagic shock.
• Patient having hemoglobin < 9 g/dl.